Please login to the form below

Not currently logged in

Boehringer lines up biosimilars of major drugs

Humira - Abbott

Prospects include copies of Humira, Avastin and MabThera

Unicheck recognised for innovation

Red Herring awardWins a Red Herring Top 100 Europe Award for anti-counterfeiting platform

Genzyme backs first International Pompe Day

International pompe dayRaises awareness of rare neuromuscular disease

GSK corruption claims extend to Jordan and Lebanon

GSK - logo on buildingFollows bribery allegations in Poland, China and Iraq

NICE gives partial backing to Ferring's prostate cancer drug

National Institute for Health and Care Excellence NICE logoFirmagon on course for use on NHS in England and Wales

BioAlliance and Topotarget merge to focus on rare cancers

BioAlliance TopotargetFrench and Danish firms combine to develop orphan oncology drugs

Sanofi takes to Twitter to support Spanish pharmacy portal

Says new account on the social network will help support community pharmacists

Menarini launches urology campaign in Greece

Menarini Greece premature ejaculation disease awarenessPE information push includes Not Just A Moment website

GSK gets OK in US for diabetes drug albiglutide

FDA headquarters White OakOnce-weekly Tanzeum will compete against Victoza and Byetta after FDA approval

This month in 1917: A tale of two Mercks

US enters World War I severing ties between Merck & Co and its German parent

Latest appointments

Featured jobs

Subscribe to our email news alerts


Add my company

PAN specialises in original, enticing, aspirational and engaging digital and print solutions to maximize brand potential ( `Influential creativity' is...

Latest intelligence

England’s clinical commissioning landscape
Who are the real masters in the new NHS?...
How will the new landscape of Hep C treatments affect patients?
The development of new therapeutic agents is set to transform the treatment of hepatitis C over the coming years....
Pharma deal watch - handshake
Pharma deals during March 2014
Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month...